AlphaQuest’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,455
Closed -$300K 1946
2025
Q4
$300K Sell
9,455
-13,100
-58% -$409K 0.02% 1210
2025
Q3
$635K Buy
22,555
+15,101
+203% +$457K 0.04% 648
2025
Q2
$274K Buy
7,454
+1,393
+23% +$48.1K 0.03% 940
2025
Q1
$238K Sell
6,061
-5,361
-47% -$241K 0.03% 902
2024
Q4
$531K Buy
11,422
+7,818
+217% +$353K 0.07% 454
2024
Q3
$163K Sell
3,604
-73
-2% -$3.47K 0.01% 1144
2024
Q2
$181K Sell
3,677
-3,901
-51% -$159K 0.02% 779
2024
Q1
$260K Buy
7,578
+7,196
+1,884% +$260K 0.05% 565
2023
Q4
$14.1K Buy
+382
New +$8.83K ﹤0.01% 980

Other funds holding TWST

AlphaQuest's TWST Position: Q1 2026 in Review

AlphaQuest sold out of Twist Bioscience (TWST) in Q1 2026, closing a stake of 9,455 shares — an estimated $300K sold.

AlphaQuest first reported a position in TWST in Q4 2023 and held it in 9 quarters. The position peaked at $635K in Q3 2025. 280 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • AlphaQuest reported no remaining Twist Bioscience position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 9,455 Twist Bioscience shares in Q1 2026, an estimated $300K.
  • AlphaQuest first reported a position in Twist Bioscience in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's Twist Bioscience position peaked at $635K in Q3 2025.
  • 280 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.